Norges Forskningsråd

• Maria Mastrangelopoulou

  PESORDNING-PESORDNING, PES_Sustainable and healthy diets for cardiovascular diseases prevention with the support of digital applications, rcn-foriss-363958, 2026, 1 Jan 2026

• Shahram Bahrami

  FORSKSYSTEMET-FORSKSYSTEMET, Unveiling Resilience: Prospectively Unravelling Factors in Alzheimer’s Disease and Related Dementias through Biostatistical Advancements, rcn-foriss-360794, 2026–2028, 1 Jan 2026

• University of Oslo

  FORSKSYSTEMET-FORSKSYSTEMET, Unveiling Resilience: Prospectively Unravelling Factors in Alzheimer’s Disease and Related Dementias through Biostatistical Advancements, rcn-foriss-360794, NOK 9m, 2026–2028, 1 Jan 2026

• Kristine B. Walhovd

  BANEBRYTENDE-BANEBRYTENDE, OrigoCogito - A network for research on relations of early life conditions and lifespan brain health, rcn-foriss-360124, 2026–2027, 1 Jan 2026

• University of Oslo

  BANEBRYTENDE-BANEBRYTENDE, OrigoCogito - A network for research on relations of early life conditions and lifespan brain health, rcn-foriss-360124, NOK 2m, 2026–2027, 1 Jan 2026

• Sigrid Berg

  NYSKAPNING-NYSKAPNING, Ultrasound technology for evaluation of sarcopenia, rcn-foriss-361801, 2026, 1 Jan 2026

• Christina Abrahamsberg

  PESORDNING-PESORDNING, Next generation cardiac MRI with manganese-based contrast agent, rcn-foriss-359468, 2025–2026, 1 Jan 2025

• Shahram Bahrami

  FRIPROSJEKT-FRIPROSJEKT, Unveiling Resilience: Prospectively Unravelling Factors in Alzheimer’s Disease and Related Dementias through Biostatistical Advancements., rcn-foriss-353629, 2025–2028, 1 Jan 2025

• University of Oslo

  FRIPROSJEKT-FRIPROSJEKT, Unveiling Resilience: Prospectively Unravelling Factors in Alzheimer’s Disease and Related Dementias through Biostatistical Advancements., rcn-foriss-353629, NOK 12m, 2025–2028, 1 Jan 2025

• Trine Ballestad Rounge

  FRIPROSJEKT-FRIPROSJEKT, CRCbiome-long: Gut dynamics in health and disease - a population-based longitudinal study, rcn-foriss-357295, 2025–2029, 1 Jan 2025

• University of Oslo

  FRIPROSJEKT-FRIPROSJEKT, CRCbiome-long: Gut dynamics in health and disease - a population-based longitudinal study, rcn-foriss-357295, NOK 12m, 2025–2029, 1 Jan 2025

• Charalampos Tzoulis

  HELSEFORSKNING-Helseforskning, GameON: Gamified Assessment and Monitoring for Early Onset of Neurological decline, rcn-foriss-356010, 2025–2026, 1 Jan 2025

• Helse Møre og Romsdal HF

  HELSEFORSKNING-Helseforskning, GameON: Gamified Assessment and Monitoring for Early Onset of Neurological decline, rcn-foriss-356010, NOK 250k, 2025–2026, 1 Jan 2025

• Kristine B. Walhovd

  HELSEFORSKNING-Helseforskning, Prevention of brain decline:general and individual factors influencing benefit from nutrition, physical activity and lifestyle interventions, rcn-foriss-356834, 2025–2028, 1 Jan 2025

• University of Oslo

  HELSEFORSKNING-Helseforskning, Prevention of brain decline:general and individual factors influencing benefit from nutrition, physical activity and lifestyle interventions, rcn-foriss-356834, NOK 4.3m, 2025–2028, 1 Jan 2025

• Pernille Thingstad

  REKRUTTERING-REKRUTTERING, Helsetjenestebruk og skrøpelighetsutvikling: Evaluering av tjenestemodeller, rcn-foriss-352608, 2025–2028, 1 Jan 2025

• Oleksii Nikolaienko

  FRIPROSJEKT-FRIPROSJEKT, Mosaic epimutations: population prevalence, mechanistic origins, and their role in cancer, rcn-foriss-354639, 2025–2029, 1 Jan 2025

• Universitetet i Bergen

  FRIPROSJEKT-FRIPROSJEKT, Mosaic epimutations: population prevalence, mechanistic origins, and their role in cancer, rcn-foriss-354639, NOK 12m, 2025–2029, 1 Jan 2025

• Tormod Fladby

  HELSEFORSKNING-Helseforskning, Finding Alzheimer’s disease progression markers, rcn-foriss-360614, 2025–2028, 1 Jan 2025

• University of Oslo

  HELSEFORSKNING-Helseforskning, Finding Alzheimer’s disease progression markers, rcn-foriss-360614, NOK 2m, 2025–2028, 1 Jan 2025

Sources: openalex.org

• Contribution of short-term changes in a composite health score on pathways linking social disadvantage and health: evidence from the UK biobank prospective cohort study

  289440, 29 Sept 2026

• NAD+ augmentation in brain aging: hype, hope, or emerging reality?

  262175, 334361, 22 Sept 2026

• Labour, capital, and the Nordic health paradox

  21 Sept 2026

• Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal

  235271, 315410, 17 Sept 2026

• Diagnostic-mortality discordance in ischaemic heart disease among patients with schizophrenia: A systematic review and meta-analysis

  11 Sept 2026

• Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research

  262175, 334361, 5 Sept 2026

• Health behaviours and telomere biology in severe mental disorders

  #223273, 2 Sept 2026

• Bump2Baby & Me+ (B2B&Me+): Protocol for a multi-country, European hybrid type 3 implementation-effectiveness study to reduce the incidence of gestational diabetes mellitus and improve maternal and child health

  31 Aug 2026

• Fitness Does Not Retire: Cardiorespiratory Fitness and Risk of Major Adverse Cardiovascular Events in Older Adults

  30 Aug 2026

• Investigating the potential causal relationship between parity and long-term maternal cardiometabolic health outcomes using Mendelian randomization

  325640, 12 Aug 2026

• Memory-related default-executive coupling across the lifespan and associations with changes in cognitive control

  325415, 6 Aug 2026

• A combined artificial intelligence-wet lab approach identifies a pivotal role of the NAD+-mitophagy axis on aging and neurodegeneration

  #262175, #334361, 1 Aug 2026

• Differences in epigenetic age acceleration according to a diagnosis of endometriosis/adenomyosis: the Norwegian Mother, Father and Child Cohort Study

  30 Mar 2026

• Modeling and evaluating longitudinal brain maintenance and cognitive reserve using episodic memory, brain structure, and functional connectivity in older adults

  21 Mar 2026

• Increased functional integration of emotional control network across the adult lifespan

  2 Mar 2026

• Resistance training partially restores age-related differences in skeletal muscle amino acid transporters - secondary analysis from two randomized controlled trials

  225258/E40, 21 Feb 2026

• The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation

  288164, 27 Jan 2026

• Reproductive history and cognitive health among older Norwegian females and males: the population-based HUNT Study

  262700, 3 Jan 2026

• NAD+ restores proteostasis through splicing-dependent autophagy

  #262175, #334361, 29 Dec 2025

• Investigating Shared Cardiovascular Factors and Genetic Overlap of Pregnancy-Related Disorders, Major Depressive Disorder, and Alzheimer's Disease

  324252, 326813, 273345, 298646, 223273, 300768, 9 Dec 2025

Sources: api.crossref.org